Tables S1-S2 Complete list of antibodies included in serum bead array (SBA) 1 and 2 (sheet 1 and 2). Table S7 Summary of antibody validation (sheet 3). (XLSX 71 kb
Table S1. Primary antibody characteristics and concentrations used in IHC assays. Table S2. Sequence...
Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb
Breast extracellular matrix (ECM) proteomic data. This table shows the ECM proteins detected in our ...
Tables S3-S6, S8, S9 and Figures S1-S7 Additional material and methods description, results and deta...
Principal Component Analysis. (a) first (x-axis) and second (y-axis) principal components capture mo...
Table S1. Residual Association of Covariates with Percent Densitya. Table S2. Association of Markers...
Table S4. The list of proteins in the IgG immunoprecipitated samples identified with at least 2 pept...
Peptide frequencies for individual proteins identified in the mass spectrometry analysis. This table...
Table S1. Candidate cancer biomarkers. Table S2. Comparisons of amino acid concentrations reported i...
Table with overview of primary antibodies. Gives information about species reactivity, suppliers and...
Table S2. List of peptides and their characteristic identified in plain IgG antibody immunoprecipita...
Figure S1. Location of differently enriched protein spots. Table S1. Averages of spot intensities of...
Table S1. Source, clone, and dilution of the antibodies used. Table S2. Basal clinicopathologic char...
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Distribution of the proportion of stroma, epithelium and adipocytes in the dense and non-dense match...
Table S1. Primary antibody characteristics and concentrations used in IHC assays. Table S2. Sequence...
Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb
Breast extracellular matrix (ECM) proteomic data. This table shows the ECM proteins detected in our ...
Tables S3-S6, S8, S9 and Figures S1-S7 Additional material and methods description, results and deta...
Principal Component Analysis. (a) first (x-axis) and second (y-axis) principal components capture mo...
Table S1. Residual Association of Covariates with Percent Densitya. Table S2. Association of Markers...
Table S4. The list of proteins in the IgG immunoprecipitated samples identified with at least 2 pept...
Peptide frequencies for individual proteins identified in the mass spectrometry analysis. This table...
Table S1. Candidate cancer biomarkers. Table S2. Comparisons of amino acid concentrations reported i...
Table with overview of primary antibodies. Gives information about species reactivity, suppliers and...
Table S2. List of peptides and their characteristic identified in plain IgG antibody immunoprecipita...
Figure S1. Location of differently enriched protein spots. Table S1. Averages of spot intensities of...
Table S1. Source, clone, and dilution of the antibodies used. Table S2. Basal clinicopathologic char...
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Distribution of the proportion of stroma, epithelium and adipocytes in the dense and non-dense match...
Table S1. Primary antibody characteristics and concentrations used in IHC assays. Table S2. Sequence...
Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb
Breast extracellular matrix (ECM) proteomic data. This table shows the ECM proteins detected in our ...